1-3 of 3
Valerie Lewington
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1/2 study of fractionated 131 I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy

Clinical Trials & Observations
Tim M. Illidge, Mike Bayne, Nicholas S. Brown, Samantha Chilton, Mark S. Cragg, Martin J. Glennie, Yong Du, Valerie Lewington, James Smart, James Thom, Maureen Zivanovic, Peter W. M. Johnson
Journal: Blood
Blood (2009) 113 (7): 1412–1421.
https://doi.org/10.1182/blood-2008-08-175653
Published: 2009
Journal Articles

Targeted Radiotherapy in the Conditioning Prior to Haematopoietic Stem Cell Transplantation: Results of a Phase I Radiation Dose Escalation Study Using Yttrium-90-Labelled Anti-CD66 Monoclonal Antibody Demonstrating High BM Uptake of Radiation.

Kim Orchard, Margaret Cooper, Valerie Lewington, Maria Tristram, Maureen Zivanovic, James Thom, Syed Quadri, Deborah Richardson, Louise Causer, Peter Johnson
Journal: Blood
Blood (2005) 106 (11): 2189.
https://doi.org/10.1182/blood.V106.11.2189.2189
Published: 2005
Journal Articles

Phase I/II Study of Fractionated Radioimmunotherapy (RIT) in Relapsed Low Grade Non-Hodgkin’s Lymphoma (NHL).

Tim M. Illidge, MD, PhD, Mike C. Bayne, MD, Maureen Zivanovic, Yong Du, MD, Valerie Lewington, MD, Johnson W. Peter, MD
Journal: Blood
Blood (2004) 104 (11): 131.
https://doi.org/10.1182/blood.V104.11.131.131
Published: 2004